Indicated in severe TBI with GCS ≤8?

Indicated in severe TBI with GCS ≤8?

• A. Indicated only when intracranial hemorrhage is present.
• B. Indicated in severe TBI (GCS ≤8) with abnormal CT or clinical deterioration; some guidelines also consider ICP monitoring even with normal CT.
• C. Indicated in all TBI patients regardless of injury severity.
• D. Never indicated in children.

Answer: (C)

The main concept here is that monitoring intracranial pressure (ICP) is a central part of managing brain injury because rising ICP drives secondary brain damage. In practice, many guidelines and experienced teams aim to monitor ICP in a broad set of patients with traumatic brain injury who require neurocritical care, since brain injury can evolve and deterioration can occur even if the initial imaging looks reasonable or the initial level of consciousness isn’t severely impaired. This means the indication can extend across the spectrum of TBI, not limited only to those with visible hemorrhage or to the most severely injured at presentation. So, the statement that ICP monitoring is indicated in all TBI patients, regardless of injury severity, reflects an inclusive approach: the goal is to detect and treat intracranial hypertension early in any patient whose brain injury necessitates ICU-level management, to prevent secondary injury and improve outcomes. The other scenarios—monitoring only for hemorrhage, only when CT is abnormal or deterioration occurs, or never in children—do not capture the broader rationale for conservative, proactive monitoring in diverse TBI cases.

The main concept here is that monitoring intracranial pressure (ICP) is a central part of managing brain injury because rising ICP drives secondary brain damage. In practice, many guidelines and experienced teams aim to monitor ICP in a broad set of patients with traumatic brain injury who require neurocritical care, since brain injury can evolve and deterioration can occur even if the initial imaging looks reasonable or the initial level of consciousness isn’t severely impaired. This means the indication can extend across the spectrum of TBI, not limited only to those with visible hemorrhage or to the most severely injured at presentation.

So, the statement that ICP monitoring is indicated in all TBI patients, regardless of injury severity, reflects an inclusive approach: the goal is to detect and treat intracranial hypertension early in any patient whose brain injury necessitates ICU-level management, to prevent secondary injury and improve outcomes. The other scenarios—monitoring only for hemorrhage, only when CT is abnormal or deterioration occurs, or never in children—do not capture the broader rationale for conservative, proactive monitoring in diverse TBI cases.